INS and Hyperglycemia: By combining automated delivery of glucagon alongside insulin, these systems aim to not only correct hyperglycaemia but also prevent or rapidly correct hypoglycaemia, something that insulin-only systems inherently struggle with due to the delayed pharmacokinetic profile of insulin analogues [41].